PPACK TFA

2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

PPACK TFA is an orally active, selective molecular glue degrader targeting IKZF2. Through a molecular glue mechanism, PPACK TFA binds to CRBN, recruits IKZF2 to form a ternary complex, and promotes its ubiquitination and proteasomal degradation. This further converts inhibitory regulatory T cells (Treg) into effector-like T cells, enhances CD8+ T cell responses, and modulates the Teff:Treg balance. PPACK TFA also increases the production of the inflammatory cytokine IL-2 and reduces the suppressive activity of Treg. PPACK TFA can be used in cancer immunotherapy research, and exhibits a synergistic effect when combined with immune checkpoint inhibitors such as anti-PD1.

For research use only. We do not sell to patients.

  • Purity: 96.79%
  • CAS No.: 157379-44-7
  • Formula: C23H32ClF3N6O5
  • Molecular Weight:564.99
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) PPACK TFA

More
Customer Validation & Images
Cell Imaging/StainingFlow CytometryIn Vivo Efficacy StudyHistological Imaging/Staining
  • Flow Cytometry
  • In Vivo Efficacy Study
  • Histological Imaging/Staining
  • Cell Imaging/Staining

All IKZF Family Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00